Teladoc (TDOC) PT Raised to $68 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
Go back to Teladoc (TDOC) PT Raised to $68 at Oppenheimer
August 3, 2018 6:39 AM EDT
Chardan Capital Markets raised its price target on Teladoc (NYSE: TDOC) to $86.00 (from $73.00) while maintaining a Buy rating.
Analyst Steven Wardell commented, "After market close on Wed., TDOC reported revenue and earnings that beat "consensus, and raised its 2018 guide. TDOCs... More
August 2, 2018 8:21 AM EDT
Cantor Fitzgerald raised its price target on Teladoc (NYSE: TDOC) to $52.00 (from $50.00) while maintaining a Neutral rating following the company's 2Q release. Revenue was $94.6 million vs. consensus of $92M. U.S. paid visits grew 41%.
Given the strong growth and including Advance Medical, TDOC... More
August 2, 2018 7:13 AM EDT
Piper Jaffray raised its price target on Teladoc (NYSE: TDOC) to $77.00 (from $55.00) while maintaining an Overweight rating following the company's 2Q earnings report. Total revenue of $94.6M was up 112% on an absolute basis and 39% organically, and beat Consensus estimates of $91.9M. EBITDA of... More
August 2, 2018 5:12 AM EDT
KeyBanc raised its price target on Teladoc (NYSE: TDOC) to $74.00 (from $70.00) while maintaining a Overweight rating.
...
More
August 1, 2018 4:07 PM EDT
Teladoc (NYSE: TDOC) reported Q2 EPS of ($0.40), $0.03 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $94.6 million versus the consensus estimate of $92.37 million.
GUIDANCE:
Teladoc sees Q3 2018 revenue of $106-108 million, versus the consensus of $105.1... More
